Gallic acid induces apoptosis and inhibits cell migration by upregulating miR-518b in SW1353 human chondrosarcoma cells

Liang,Wenna; Li,Xihai; Li,Yachan; Li,Candong; Gao,Bizheng; Gan,Huijuan; Li,Sumin; Shen,Jianying; Kang,Jie; Ding,Shanshan; Lin,Xuejuan; Liao,Linghong

doi:10.3892/ijo.2013.2155

Gallic acid induces apoptosis and inhibits cell migration by upregulating miR-518b in SW1353 human chondrosarcoma cells

Authors:
- Wenna Liang
- Xihai Li
- Yachan Li
- Candong Li
- Bizheng Gao
- Huijuan Gan
- Sumin Li
- Jianying Shen
- Jie Kang
- Shanshan Ding
- Xuejuan Lin
- Linghong Liao
View Affiliations

Affiliations: Research Base of Traditional Chinese Medicine Syndrome, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, P.R. China, Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, P.R. China, The Affiliated People's Hospital, Fujian University of Traditional Chinese Medicine, Fuzhou 350004, P.R. China
Published online on: October 30, 2013 https://doi.org/10.3892/ijo.2013.2155
Pages: 91-98

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Gallic acid (GA), a natural agent, is widely distributed in plants with a range of biological effects and has been of potential interest as anticancer agent. However, its effects on chondrosarcoma cell apoptosis are still undefined. In the present study, the possible mechanisms of GA-induced apoptosis were explored in SW1353 cells, a human chondrosarcoma cell line. Our results showed that GA inhibited cell viability dose- and time-dependently. Morphological examination of GA-treated cells exhibited the typical features of cell death, such as rounding up of the cells and cell shrinkage. Wound-healing assay indicated that GA inhibited the migratory abilities of SW1353 cells. Hoechst 33258 staining assay and Annexin V/PI staining assay exhibited apoptosis induction by GA. To determine the molecular mechanism of GA-induced apoptosis, the expression levels Bcl-2, Bax, caspase-3 and caspase-9 were determined in SW1353 cells treated with GA. We found that GA downregulated the expression of the anti-apoptotic protein Bcl-2, and upregulated the expression of the pro-apoptotic protein Bax, and the activation of caspase-3 and caspase-9. To identify the possible mechanisms, the changes of microRNA expression were tested using the miRCURY™ LNA expression array. It was observed that the miR-518b gene was upregulated in treated cells. Taken together, these data show that GA induces apoptosis and inhibits cell migration by upregulating miR-518b in SW1353 cells.

View Figures

View References

1.	Schrage YM, Briaire-De Bruijn IH, De Miranda NF, et al: Kinome profiling of chondrosarcoma reveals SRC-pathway activity and dasatinib as option for treatment. Cancer Res. 69:6216–6222. 2009. View Article : Google Scholar : PubMed/NCBI
2.	Li X, Ye H, Cai L, et al: Millimeter wave radiation induces apoptosis via affecting the ratio of Bax/Bcl-2 in SW1353 human chondrosarcoma cells. Oncol Rep. 27:664–672. 2012.PubMed/NCBI
3.	Dickey ID, Rose PS, Fuchs B, et al: Dedifferentiated chondrosarcoma: the role of chemotherapy with updated outcomes. J Bone Joint Surg Am. 86:2412–2418. 2004.PubMed/NCBI
4.	Kalinski T, Sel S, Kouznetsova I, Röpke M and Roessner A: Heterogeneity of angiogenesis and blood vessel maturation in cartilage tumors. Pathol Res Pract. 205:339–345. 2009. View Article : Google Scholar : PubMed/NCBI
5.	Yuan J, Dutton CM and Scully SP: RNAi mediated MMP-1 silencing inhibits human chondrosarcoma invasion. J Orthop Res. 23:1467–1474. 2005. View Article : Google Scholar : PubMed/NCBI
6.	Gelderblom H, Hogendoorn PC, Dijkstra SD, et al: The clinical approach towards chondrosarcoma. Oncologist. 13:320–329. 2008. View Article : Google Scholar : PubMed/NCBI
7.	Bovée JV, Cleton-Jansen AM, Taminiau AH and Hogendoorn PC: Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment. Lancet Oncol. 6:599–607. 2005.PubMed/NCBI
8.	Zuntini M, Salvatore M, Pedrini E, et al: MicroRNA profiling of multiple osteochondromas: identification of disease-specific and normal cartilage signatures. Clin Genet. 78:507–516. 2010. View Article : Google Scholar : PubMed/NCBI
9.	Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
10.	Wang W, Zhao LJ, Tan YX, Ren H and Qi ZT: MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma. Carcinogenesis. 33:1113–1120. 2012. View Article : Google Scholar : PubMed/NCBI
11.	He L and Hannon GJ: MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004. View Article : Google Scholar : PubMed/NCBI
12.	Anglicheau D, Muthukumar T and Suthanthiran M: MicroRNAs: small RNAs with big effects. Transplantation. 90:105–112. 2010. View Article : Google Scholar : PubMed/NCBI
13.	Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
14.	Esquela-Kerscher A and Slack FJ: Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006. View Article : Google Scholar
15.	Locatelli C, Filippin-Monteiro FB and Creczynski-Pasa TB: Alkyl esters of gallic acid as anticancer agents: a review. Eur J Med Chem. 60:233–239. 2013. View Article : Google Scholar : PubMed/NCBI
16.	Verma S, Singh A and Mishra A: Gallic acid: molecular rival of cancer. Environ Toxicol Pharmacol. 35:473–485. 2013. View Article : Google Scholar : PubMed/NCBI
17.	Kim YJ: Antimelanogenic and antioxidant properties of gallic acid. Biol Pharm Bull. 30:1052–1055. 2007. View Article : Google Scholar : PubMed/NCBI
18.	Panich U, Onkoksoong T, Limsaengurai S, Akarasereenont P and Wongkajornsilp A: UVA-induced melanogenesis and modulation of glutathione redox system in different melanoma cell lines: the protective effect of gallic acid. J Photochem Photobiol B. 108:16–22. 2012. View Article : Google Scholar : PubMed/NCBI
19.	Shahrzad S, Aoyagi K, Winter A, Koyama A and Bitsch I: Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humans. J Nutr. 131:1207–1210. 2001.PubMed/NCBI
20.	Zhang M, Zhou S, Zhang L, et al: miR-518b is down-regulated, and involved in cell proliferation and invasion by targeting Rap1b in esophageal squamous cell carcinoma. FEBS Lett. 586:3508–3521. 2012. View Article : Google Scholar : PubMed/NCBI
21.	Liang W, Li X, Li C, et al: Quercetin-mediated apoptosis via activation of the mitochondrial-dependent pathway in MG-63 osteosarcoma cells. Mol Med Rep. 4:1017–1023. 2011.PubMed/NCBI
22.	Kim HJ, Lee SG, Kim YJ, et al: Cytoprotective role of autophagy during paclitaxel-induced apoptosis in Saos-2 osteosarcoma cells. Int J Oncol. 42:1985–1992. 2013.PubMed/NCBI
23.	Kim SY and Helman LJ: Strategies to explore new approaches in the investigation and treatment of osteosarcoma. Cancer Treat Res. 152:517–528. 2009. View Article : Google Scholar : PubMed/NCBI
24.	Russinoff S, Miran S, Gowda AL and Lucas PA: Osteosarcoma cells differentiate into phenotypes from all three dermal layers. Clin Orthop Relat Res. 469:2895–2904. 2011. View Article : Google Scholar : PubMed/NCBI
25.	Liang CZ, Zhang X, Li H, et al: Gallic acid induces the apoptosis of human osteosarcoma cells in vitro and in vivo via the regulation of mitogen-activated protein kinase pathways. Cancer Biother Radiopharm. 27:701–710. 2012. View Article : Google Scholar : PubMed/NCBI
26.	Liao CL, Lai KC, Huang AC, et al: Gallic acid inhibits migration and invasion in human osteosarcoma U-2 OS cells through suppressing the matrix metalloproteinase-2/-9, protein kinase B (PKB) and PKC signaling pathways. Food Chem Toxicol. 50:1734–1740. 2012. View Article : Google Scholar
27.	Nagata S: Apoptosis by death factor. Cell. 88:355–365. 1997. View Article : Google Scholar : PubMed/NCBI
28.	Circu ML and Aw TY: Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med. 48:749–762. 2010. View Article : Google Scholar : PubMed/NCBI
29.	Du C, Fang M, Li Y, Li L and Wang X: Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell. 102:33–42. 2000. View Article : Google Scholar : PubMed/NCBI
30.	Danial NN and Korsmeyer SJ: Cell death: critical control points. Cell. 116:205–219. 2004. View Article : Google Scholar : PubMed/NCBI
31.	Low IC, Kang J and Pervaiz S: Bcl-2: a prime regulator of mitochondrial redox metabolism in cancer cells. Antioxid Redox Signal. 15:2975–2987. 2011. View Article : Google Scholar : PubMed/NCBI
32.	Del Gaizo Moore V and Letai A: BH3 profiling-measuring integrated function of the mitochondrial apoptotic pathway to predict cell fate decisions. Cancer Lett. 332:202–205. 2013.PubMed/NCBI
33.	Fernández-Luna JL: Apoptosis regulators as targets for cancer therapy. Clin Transl Oncol. 9:555–562. 2007.
34.	Lalier L, Cartron PF, Juin P, et al: Bax activation and mitochondrial insertion during apoptosis. Apoptosis. 12:887–896. 2007. View Article : Google Scholar : PubMed/NCBI
35.	Thorns C, Kuba J, Bernard V, et al: Deregulation of a distinct set of microRNAs is associated with transformation of gastritis into MALT lymphoma. Virchows Arch. 460:371–377. 2012. View Article : Google Scholar : PubMed/NCBI
36.	Lima RT, Busacca S, Almeida GM, Gaudino G, Fennell DA and Vasconcelos MH: MicroRNA regulation of core apoptosis pathways in cancer. Eur J Cancer. 47:163–174. 2011. View Article : Google Scholar : PubMed/NCBI
37.	Creighton CJ, Fountain MD, Yu Z, et al: Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers. Cancer Res. 70:1906–1915. 2010. View Article : Google Scholar : PubMed/NCBI
38.	Cai CK, Zhao GY, Tian LY, et al: miR-15a and miR-16-1 down-regulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma. Oncol Rep. 28:1764–1770. 2012.PubMed/NCBI